- Home
- Publications
- Publication Search
- Publication Details
Title
Low-dose IL-2 therapy in autoimmune diseases: An update review
Authors
Keywords
-
Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume -, Issue -, Pages 1-25
Publisher
Informa UK Limited
Online
2023-10-26
DOI
10.1080/08830185.2023.2274574
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GVHD prophylaxis: use an ortho IL-2/IL-2Rβ Treg system!
- (2023) Dietlinde Wolf BLOOD
- Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials
- (2023) Sefina Arif et al. Frontiers in Immunology
- Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
- (2023) Manish Dhawan et al. Vaccines
- Low-dose Interleukin-2 For Psoriasis Therapy Based on the Regulation of Th17/Treg Cell Balance in Peripheral Blood
- (2023) Zusha Qiao et al. INFLAMMATION
- More evidence for low-dose IL-2 for chronic GVHD in children
- (2023) John E. Levine Blood Advances
- RORγt+Foxp3+ regulatory T cells in the regulation of autoimmune arthritis
- (2022) Kotona Furuyama et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Regulatory T Cells in Immunopathogenesis and Severity of COVID-19: A Systematic Review
- (2022) Sam Alahyari et al. Archives of Iranian Medicine
- Therapeutic potential of interleukin-2 in autoimmune diseases
- (2022) Yeshuang Yuan et al. TRENDS IN MOLECULAR MEDICINE
- Th1-Like Treg Cells Are Increased But Deficient in Function in Rheumatoid Arthritis
- (2022) Rui Zhang et al. Frontiers in Immunology
- T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
- (2022) Anselm Mak Cells
- Immunomodulatory Properties of Pomegranate Peel Extract in a Model of Human Peripheral Blood Mononuclear Cell Culture
- (2022) Miodrag Čolić et al. Pharmaceutics
- A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
- (2022) Jennifer Whangbo et al. Blood Advances
- The IL-2A receptor pathway and its role in lymphocyte differentiation and function
- (2022) Yuqian Li et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Migration and homeostasis of regulatory T cells in rheumatoid arthritis
- (2022) Konstantin Kotschenreuther et al. Frontiers in Immunology
- Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
- (2022) Sara Bolivar-Wagers et al. JCI Insight
- Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection
- (2022) Derek VanDyke et al. Cell Reports
- Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo
- (2022) Teresa Lopes Ramos et al. BLOOD
- Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
- (2022) Janne Verreycken et al. Human Vaccines & Immunotherapeutics
- Diesel Exhaust Particulates Enhances Susceptibility of LPS-Induced Acute Lung Injury through Upregulation of the IL-17 Cytokine-Derived TGF-β1/Collagen I Expression and Activation of NLRP3 Inflammasome Signaling in Mice
- (2021) Dong Im Kim et al. Biomolecules
- Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity
- (2021) Qingxiao Song et al. BLOOD
- Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
- (2021) Hanna Graßhoff et al. Frontiers in Immunology
- miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases
- (2021) Junxia Huang et al. Frontiers in Immunology
- The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes
- (2021) Shen Dong et al. JCI Insight
- Low-dose interleukin-2: A potential treatment for pemphigus vulgaris
- (2021) Hai Long et al. AUTOIMMUNITY REVIEWS
- Interleukin-2 and regulatory T cells in rheumatic diseases
- (2021) Antonios G. A. Kolios et al. Nature Reviews Rheumatology
- Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus
- (2021) Pengcheng Zhou et al. PLoS Pathogens
- Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
- (2021) Jenny Bulgarelli et al. Frontiers in Immunology
- Newly Found Peacekeeper: Potential of CD8+ Tregs for Graft-Versus-Host Disease
- (2021) Weihao Wang et al. Frontiers in Immunology
- T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
- (2021) Hua Jiang et al. Frontiers in Immunology
- Platelets in ITP: Victims in Charge of Their Own Fate?
- (2021) Vivianne S. Nelson et al. Cells
- Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation
- (2020) Alessandra Colamatteo et al. Frontiers in Immunology
- Low Dose IL-2 Combined with Rapamycin Led to an Expansion of CD4+CD25+FOXP3+ Tregs and Prolonged Human Islet-allograft Survival in Humanized Mice
- (2020) Min Hu et al. DIABETES
- E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases
- (2020) Zijun Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Low-dose Interleukin-2: Biology and therapeutic prospects in rheumatoid arthritis
- (2020) Ruihe Wu et al. AUTOIMMUNITY REVIEWS
- Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
- (2020) Michelle Rosenzwajg et al. DIABETOLOGIA
- COVID ‐19 acute respiratory distress syndrome ( ARDS ): clinical features and differences from typical pre‐ COVID ‐19 ARDS
- (2020) Peter G Gibson et al. MEDICAL JOURNAL OF AUSTRALIA
- Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
- (2020) Aazam Ghelani et al. Frontiers in Immunology
- Hypomyopathic Dermatomyositis with Refractory Dermatitis Treated by Low-dose IL-2
- (2020) Miao Miao et al. Dermatology and Therapy
- An update on the pathophysiology of immune thrombocytopenia
- (2020) John W. Semple et al. CURRENT OPINION IN HEMATOLOGY
- Low dose IL-2 for treating moderate to severe alopecia areata. A 52 weeks multicenter prospective placebo-controlled study assessing its impact on T regulatory cells and natural killer populations
- (2020) Florence Le Duff et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
- (2020) Liliane Khoryati et al. Science Immunology
- Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions
- (2020) Nuria Martinez-Cibrian et al. BLOOD REVIEWS
- Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis
- (2020) Laura Elisa Buitrago-Molina et al. JOURNAL OF AUTOIMMUNITY
- Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
- (2019) Elizabeth I. Buchbinder et al. Journal for ImmunoTherapy of Cancer
- Essential and non-overlapping IL-2Rα-dependent processes for thymic development and peripheral homeostasis of regulatory T cells
- (2019) Kevin H. Toomer et al. Nature Communications
- Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia
- (2019) Richard Vollenberg et al. HAEMATOLOGICA
- Mechanisms of human Foxp3+ Treg cell development and function in health and disease
- (2019) Mikhael Attias et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Helper T cell differentiation
- (2019) Jordy Saravia et al. Cellular & Molecular Immunology
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- (2019) Jing He et al. ANNALS OF THE RHEUMATIC DISEASES
- Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas
- (2019) Dana N. LeVine et al. VETERINARY CLINICAL PATHOLOGY
- Systemic Lupus Erythematosus and DNA Degradation and Elimination Defects
- (2019) Borros Arneth Frontiers in Immunology
- Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
- (2019) Maryam Tahvildari et al. JOURNAL OF IMMUNOLOGY
- Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis
- (2019) Ronald Man Lung Yip et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Editorial: Mechanisms by Which SLE-Associated Genetic Variants Contribute to SLE Pathogenesis
- (2019) José C. Crispín et al. Frontiers in Immunology
- Signaling and Function of Interleukin-2 in T Lymphocytes
- (2018) Sarah H. Ross et al. Annual Review of Immunology
- Alopecia areata: a review of disease pathogenesis
- (2018) F. Rajabi et al. BRITISH JOURNAL OF DERMATOLOGY
- Pathophysiology of immune thrombocytopenia
- (2018) June Li et al. CURRENT OPINION IN HEMATOLOGY
- Therapeutic potential of low-dose IL-2 in immune thrombocytopenia: An analysis of 3 cases
- (2018) Jiakui Zhang et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Low Dose Interleukin-2 for Refractory Autoimmune Hepatitis
- (2018) Tiong Y. Lim et al. HEPATOLOGY
- Tocilizumab in the treatment of adult rheumatoid arthritis
- (2018) Raimon Sanmartí et al. Immunotherapy
- Biology of IL-2 and its therapeutic modulation: Mechanisms and strategies
- (2018) Suman Mitra et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Prospects of IL-2 in Cancer Immunotherapy
- (2018) Hani Choudhry et al. Biomed Research International
- IL-2–Anti–IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell Functions
- (2018) Yuichi Yokoyama et al. JOURNAL OF IMMUNOLOGY
- Role of Cytokine Combinations on CD4+ T Cell Differentiation, Partial Polarization, and Plasticity: Continuous Network Modeling Approach
- (2018) Mariana E. Martinez-Sanchez et al. Frontiers in Physiology
- IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren’s Syndrome Patients
- (2018) Jing Luo et al. Frontiers in Immunology
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
- (2018) Michelle Rosenzwajg et al. ANNALS OF THE RHEUMATIC DISEASES
- Low-dose interleukin-2 therapy for the treatment of systemic lupus erythematosus
- (2018) Jens Y. Humrich et al. CURRENT OPINION IN RHEUMATOLOGY
- A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
- (2018) Laurence B. Peterson et al. JOURNAL OF AUTOIMMUNITY
- Differential Roles of IL-2 Signaling in Developing versus Mature Tregs
- (2018) Martin Y. Fan et al. Cell Reports
- Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2—A Balancing Act
- (2018) Vandana Kalia et al. Frontiers in Immunology
- Defective T-Cell Apoptosis and T-Regulatory Cell Dysfunction in Rheumatoid Arthritis
- (2018) Charles Malemud Cells
- IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus
- (2017) Hong Dai et al. JOURNAL OF IMMUNOLOGY
- Regulatory T cells in multiple sclerosis and myasthenia gravis
- (2017) K. M. Danikowski et al. Journal of Neuroinflammation
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- (2017) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells
- (2017) Ji-Jing Yan et al. KIDNEY INTERNATIONAL
- Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis
- (2017) Deepak A. Rao et al. NATURE
- Emerging targets in cancer immunotherapy
- (2017) Samantha Burugu et al. SEMINARS IN CANCER BIOLOGY
- Role of IL-17 in LPS-induced acute lung injury: an in vivo study
- (2017) Qi Ding et al. Oncotarget
- Developmental and Functional Control of Natural Killer Cells by Cytokines
- (2017) Yang Wu et al. Frontiers in Immunology
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- The Inflammatory Response in Psoriasis: a Comprehensive Review
- (2016) Yaxiong Deng et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia
- (2016) Jiakui Zhang et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Long-term side effects of glucocorticoids
- (2016) Merih Oray et al. Expert Opinion On Drug Safety
- An essential role for the IL-2 receptor in Treg cell function
- (2016) Takatoshi Chinen et al. NATURE IMMUNOLOGY
- Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
- (2016) Jing He et al. NATURE MEDICINE
- Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
- (2016) John A. Todd et al. PLOS MEDICINE
- Regulatory T Cells: Differentiation and Function
- (2016) G. Plitas et al. Cancer Immunology Research
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
- (2015) Caroline von Spee-Mayer et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
- (2015) Jens Y Humrich et al. ANNALS OF THE RHEUMATIC DISEASES
- The therapeutic potential of regulatory T cells for the treatment of autoimmune disease
- (2015) Jeffrey A Bluestone et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression
- (2015) Rodrigo Liberal et al. HEPATOLOGY
- Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
- (2015) Jamie B. Spangler et al. IMMUNITY
- Manipulating IL-2 and IL-2R in autoimmune diseases and transplantation
- (2015) Mei Zhang et al. Immunotherapy
- Digoxin ameliorates autoimmune arthritis via suppression of Th17 differentiation
- (2015) Jennifer Lee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- (2015) Michelle Rosenzwajg et al. JOURNAL OF AUTOIMMUNITY
- Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Waleed Ghanima et al. LANCET
- Immune homeostasis enforced by co-localized effector and regulatory T cells
- (2015) Zhiduo Liu et al. NATURE
- IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy
- (2015) Ee W. Su et al. Science Translational Medicine
- Interleukin-2: Biology, Design and Application
- (2015) Natalia Arenas-Ramirez et al. TRENDS IN IMMUNOLOGY
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. Arthritis & Rheumatology
- Administration of Low Doses of IL-2 Combined to Rapamycin Promotes Allogeneic Skin Graft Survival in Mice
- (2014) C. B. Pilon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Th17 cells in inflammation and autoimmunity
- (2014) Ram Pyare Singh et al. AUTOIMMUNITY REVIEWS
- Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
- (2014) Mélissa Noack et al. AUTOIMMUNITY REVIEWS
- How we treat chronic graft-versus-host disease
- (2014) M. E. D. Flowers et al. BLOOD
- Rapamycin: One Drug, Many Effects
- (2014) Jing Li et al. Cell Metabolism
- Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
- (2014) Michelle Rosenzwajg et al. Current Diabetes Reports
- Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells
- (2014) M. S. Wilson et al. JOURNAL OF IMMUNOLOGY
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- (2014) Brittany G. Craiglow et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- (2014) Luzhou Xing et al. NATURE MEDICINE
- Pathogenesis of immune thrombocytopenia
- (2014) Douglas B. Cines et al. PRESSE MEDICALE
- Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
- (2014) Emeline Castela et al. JAMA Dermatology
- High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
- (2014) Janice P Dutcher et al. Journal for ImmunoTherapy of Cancer
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- Impaired inhibitory function of circulating CD4+CD25+ regulatory T cells in alopecia areata
- (2013) Bong Seok Shin et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- CD4+CD25+Foxp3+ Regulatory T Cells in the Pathophysiology of Immune Thrombocytopenia
- (2013) Tetsuya Nishimoto et al. SEMINARS IN HEMATOLOGY
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Generation and Function of Induced Regulatory T Cells
- (2013) Erica G. Schmitt et al. Frontiers in Immunology
- Low-Dose IL-2 for In Vivo Expansion of CD4+ and CD8+ Regulatory T Cells in Nonhuman Primates
- (2012) A. Aoyama et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-term complications of past glucocorticoid use
- (2012) Luciana P.C. Seguro et al. AUTOIMMUNITY REVIEWS
- CD4+T Cells: Differentiation and Functions
- (2012) Rishi Vishal Luckheeram et al. Clinical & Developmental Immunology
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function
- (2012) Jian-Xin Lin et al. IMMUNITY
- Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
- (2012) André Ballesteros-Tato et al. IMMUNITY
- Interleukin-2/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2/STAT5 signalling pathways
- (2012) Seon-Yeong Lee et al. IMMUNOLOGY
- Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood
- (2012) Huahua Fan et al. IMMUNOLOGY
- IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death
- (2012) Motoko Y Kimura et al. NATURE IMMUNOLOGY
- Acquired STAT4 deficiency as a consequence of cancer chemotherapy
- (2011) I. P. Lupov et al. BLOOD
- Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
- (2011) S. Audia et al. BLOOD
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells
- (2011) Guoyan Cheng et al. IMMUNOLOGICAL REVIEWS
- The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4+ FoxP3+ regulatory T cells
- (2011) Xin Chen et al. IMMUNOLOGY
- Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells
- (2011) Xin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells
- (2011) Sau K. Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game
- (2011) S. A. Long et al. JOURNAL OF IMMUNOLOGY
- Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens
- (2011) R. W. DePaolo et al. NATURE
- The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
- (2011) Greg M Delgoffe et al. NATURE IMMUNOLOGY
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
- (2010) J. L. Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract
- (2010) Carlos Sostres et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- FOXP3 and RORγt: Transcriptional regulation of Treg and Th17
- (2010) Zuojia Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cutting Edge: Mechanisms of IL-2-Dependent Maintenance of Functional Regulatory T Cells
- (2010) L. Barron et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6-lpr/lpr Mice
- (2010) V. C. Kyttaris et al. JOURNAL OF IMMUNOLOGY
- Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
- (2009) Ji Yang et al. ARTHRITIS AND RHEUMATISM
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus
- (2009) J. Y. Humrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells
- (2009) R. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How do Regulatory T Cells Work?
- (2009) A. Corthay SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
- (2008) Harald E. Vonkeman et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started